Results 231 to 240 of about 1,080,358 (387)

Detection of C-Type natriuretic peptide compared with brain and atrial natriuretic peptide transcripts in human heart by the polymerase chain reaction [PDF]

, 1993
Gerbes, Alexander L., Nemer, M.
core   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Action on elevated natriuretic peptide in primary care: a retrospective cohort study. [PDF]

BJGP Open
Vermeer CJ, Hollander M, Stolk AJ, Groenewegen A, Geersing GJ, Rutten FH, Hart HE.   +6 more
europepmc   +1 more source

ATRIAL NATRIURETIC PEPTIDE RND THE RENAL EFFECTS OF PEEP VENTILATION [PDF]

, 1987
E D Kharasch, K. -T. Yeo, L. Laposky, M A Kenny, Charles W. Buffington   +4 more
openalex   +1 more source

Atrial natriuretic peptide. [PDF]

Archives of Disease in Childhood, 1992
J. Midgley, Neema Modi
openaire   +3 more sources

Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine

ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi, Alvin Chandra, Ambarish Pandey, Marco Metra   +3 more
wiley   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

The Effects of the Natriuretic Peptide System on Alveolar Epithelium in Heart Failure. [PDF]

Int J Mol Sci
Knany Y, Kinaneh S, Khoury EE, Zohar Y, Abassi Z, Azzam ZS.   +5 more
europepmc   +1 more source

ATRIAL NATRIURETIC PEPTIDE IN CHILDREN — THE HEART AS AN ENDOCRINE ORGAN [PDF]

, 1985
J Weil, F. Bidlingmaier, C Döhlemann, D Knorr, Ursula Kuhnle, Marcel J. Vogel, Re L   +6 more
openalex   +1 more source

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats

ESC Heart Failure, Volume 12, Issue 2, Page 1304-1315, April 2025.
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén, Bård Andre Bendiksen, Kaja Knudsen Bergo, Emil Knut Stenersen Espe, Gary McGinley, Almira Hasic, Ida Marie Hauge‐Iversen, Hege Katrin Ugland, Xin Shen, Michael Frisk, Nishani S. Mabotuwana, William E. Louch, Rizwan I. Hussain, Lili Zhang, Ivar Sjaastad, Alessandro Cataliotti, Geir Christensen   +16 more
wiley   +1 more source